Overview
Primary interstitial lung disease specific to childhood (chILD) is a heterogeneous group of rare respiratory disorders that predominantly affect the lung interstitium — the tissue and space around the air sacs (alveoli) — in infants and children. Unlike interstitial lung diseases seen in adults, these childhood-specific forms involve distinct entities related to abnormal lung development, surfactant metabolism dysfunction, and other processes unique to the growing lung. This group encompasses conditions such as neuroendocrine cell hyperplasia of infancy (NEHI), pulmonary interstitial glycogenosis, diffuse developmental disorders of the lung, and surfactant protein deficiencies (including mutations in SFTPB, SFTPC, ABCA3, and NKX2-1). Key symptoms include persistent tachypnea (rapid breathing), hypoxemia (low blood oxygen levels), chronic cough, failure to thrive, exercise intolerance, and respiratory distress that may present from the neonatal period through later childhood. Chest imaging typically reveals diffuse infiltrates, ground-glass opacities, or other interstitial patterns, and lung biopsy may be required for definitive diagnosis in some subtypes. The severity ranges widely — from mild disease with gradual improvement to severe, life-threatening respiratory failure. Treatment is largely supportive and depends on the specific subtype. Supplemental oxygen therapy is commonly required, and nutritional support is important for children with failure to thrive. Systemic corticosteroids and hydroxychloroquine are used in some forms, though evidence for their efficacy remains limited. In the most severe cases, particularly those involving surfactant protein B deficiency, lung transplantation may be the only definitive treatment option. Management is best coordinated through multidisciplinary teams at specialized pediatric centers. Because this is a grouping category rather than a single disease entity, the inheritance pattern, prognosis, and treatment response vary considerably depending on the underlying diagnosis.
Also known as:
Variable
Can be inherited in different ways depending on the underlying gene
Variable
Can begin at different ages, from infancy through adulthood
Treatments
No FDA-approved treatments are currently listed for Primary interstitial lung disease specific to childhood.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Primary interstitial lung disease specific to childhood at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for Primary interstitial lung disease specific to childhood.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Primary interstitial lung disease specific to childhood.
Community
No community posts yet. Be the first to share your experience with Primary interstitial lung disease specific to childhood.
Start the conversation →Latest news about Primary interstitial lung disease specific to childhood
No recent news articles for Primary interstitial lung disease specific to childhood.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Primary interstitial lung disease specific to childhood
What is Primary interstitial lung disease specific to childhood?
Primary interstitial lung disease specific to childhood (chILD) is a heterogeneous group of rare respiratory disorders that predominantly affect the lung interstitium — the tissue and space around the air sacs (alveoli) — in infants and children. Unlike interstitial lung diseases seen in adults, these childhood-specific forms involve distinct entities related to abnormal lung development, surfactant metabolism dysfunction, and other processes unique to the growing lung. This group encompasses conditions such as neuroendocrine cell hyperplasia of infancy (NEHI), pulmonary interstitial glycogeno